-
Product Insights
Serine/Threonine Protein Kinase B Raf – Drugs In Development, 2023
Global Markets Direct’s Serine/Threonine Protein Kinase B Raf provides in depth analysis on Serine/Threonine Protein Kinase B Raf targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Serine/Threonine...
-
Product Insights
RAF Proto Oncogene Serine/Threonine Protein Kinase – Drugs In Development, 2023
Global Markets Direct’s RAF Proto Oncogene Serine/Threonine Protein Kinase provides in depth analysis on RAF Proto Oncogene Serine/Threonine Protein Kinase targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved...
-
Product Insights
RAF Coltishall Solar PV Park
RAF Coltishall Solar PV Park is a solar PV project located in England, United Kingdom. The project is owned by Greencoat Solar I LP and was developed by Red Triangle Energy Ltd. The project came online in 2015. Empower your strategies with our RAF Coltishall Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the...
-
Product Insights
RAF Desborough Solar PV Park
RAF Desborough Solar PV Park is a solar PV project located in England, United Kingdom. The project is owned by Stantec Inc and is developed by NF Raf Desb Ltd; Stantec Inc. The project is at the permitting stage. Empower your strategies with our RAF Desborough Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of...
-
Product Insights
RAF West Raynham Solar PV Park
RAF West Raynham Solar PV Park is a solar PV project located in England, United Kingdom. The project is owned by Bluefield Solar Income Fund Ltd and was developed by Trina Solar Co Ltd. The project came online in 2015. Empower your strategies with our RAF West Raynham Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business...
-
Product Insights
Lark RAF Stradishall Solar PV Park
Lark RAF Stradishall Solar PV Park is a solar PV project located in England, United Kingdom. The project is owned by Santander UK PLC and was developed by Lark Energy Ltd (Inactive). The project came online in 2013. Empower your strategies with our Lark RAF Stradishall Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Avutometinib Potassium in Cervical Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Avutometinib Potassium in Cervical Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Avutometinib Potassium in Cervical Cancer Drug Details: Avutometinib potassium (RG-7304,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Avutometinib Potassium in Follicular Thyroid Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Avutometinib Potassium in Follicular Thyroid Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Avutometinib Potassium in Follicular Thyroid Cancer Drug Details: Avutometinib...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Avutometinib Potassium in Anaplastic Thyroid Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Avutometinib Potassium in Anaplastic Thyroid Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Avutometinib Potassium in Anaplastic Thyroid Cancer Drug Details: Avutometinib...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Avutometinib Potassium in Papillary Thyroid Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Avutometinib Potassium in Papillary Thyroid Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Avutometinib Potassium in Papillary Thyroid Cancer Drug Details: Avutometinib...